The global direct-to-consumer genetic testing market size was estimated at USD 2.32 billion in 2025 and is projected to reach USD 6.80 billion by 2033, growing at a CAGR of 14.0% from 2026 to 2033. The market growth is driven by the prevalence of chronic diseases, a stronger emphasis on ... Read More »
May 2026The U.S. non-invasive cancer diagnostics market was estimated at USD 27.08 billion in 2025 and is projected to reach USD 47.52 billion in 2033, growing at a CAGR of 7.4% from 2026 to 2033. The growth is driven by the continuous advancements in diagnostic technologies, the rising prevalen... Read More »
May 2026The global blood group typing market was valued at USD 2.31 billion in 2025 and is projected to reach USD 5.59 billion by 2033, growing at a CAGR of 11.99% from 2026 to 2033. Market growth is driven by the rising burden of chronic diseases such as anemia, cancer, and blood disorders, which increases the need for fre... Read More »
April 2026The global pancreatic cancer diagnostic market size was estimated at USD 2.80 billion in 2025 and is projected to reach USD 5.15 billion by 2033, growing at a CAGR of 6.83% from 2026 to 2033. The increasing prevalence of pancreatic cancer, the growing emphasis on early detection, and adv... Read More »
April 2026The global real-time PCR, digital PCR, and end-point PCR market size was valued at USD 10.58 billion in 2025 and is expected to reach USD 21.31 billion by 2033, growing at a CAGR of 9.2% from 2026 to 2033. Market growth is driven by the rising prevalence of infectious diseases and cancer... Read More »
April 2026The global high-throughput genomic screening for preventive healthcare market size was estimated at USD 846.05 million in 2025 and is projected to reach USD 2,169.74 million by 2033, growing at a CAGR of 12.6% from 2026 to 2033. The market growth is driven by the transition from reactive... Read More »
April 2026The global laser-induced fluorescence detection instruments market size was estimated at USD 846.05 million in 2025 and is projected to reach USD 2,169.74 million by 2033, growing at a CAGR of 12.61% from 2026 to 2033. The laser-induced fluorescence (LIF) detection instruments industry g... Read More »
April 2026The global direct-to-consumer testing market size was estimated at USD 4.70 billion in 2025 and is projected to reach USD 16.05 billion by 2033, growing at a CAGR of 14.51% from 2026 to 2033. This growth is driven by the rising prevalence of chronic diseases, an increasing emphasis on pr... Read More »
April 2026The global polymerase chain reaction market size was estimated at USD 15.19 billion in 2025 and is projected to reach USD 24.78 billion by 2033, growing at a CAGR of 6.36% from 2026 to 2033. The market growth is driven by the increasing demand for rapid and accurate molecular diagnostics across clinical, research, a... Read More »
April 2026The global at-home chronic disease biomarker testing market size was estimated at USD 5.04 billion in 2025 and is projected to reach USD 18.68 billion by 2033, growing at a CAGR of 17.79% from 2026 to 2033. This growth is driven by the rising prevalence of chronic diseases, an increasing... Read More »
April 2026The global at-home blood collection kits and devices market size was estimated at USD 193.42 million in 2025 and is anticipated to reach USD 381.97 million by 2033, growing at a CAGR of 8.92% from 2026 to 2033. The rising burden of blood-related disorders primarily drives the growth. The... Read More »
April 2026The U.S. infectious respiratory disease diagnostics market size was estimated at USD 4.50 billion in 2025 and is projected to reach USD 5.70 billion by 2033, growing at a CAGR of 2.98% from 2026 to 2033, driven by the sustained and recurring burden of viral and bacterial respiratory infe... Read More »
April 2026The U.S. drug testing market size was estimated at USD 2.62 billion in 2025, projected to reach USD 4.13 billion by 2033, expanding at a CAGR of 5.89% from 2026 to 2033. The growth of the market is driven by rising prevalence of substance abuse, stringent regulations requiring drug &... Read More »
April 2026The global rare disease genetic testing market size was estimated at USD 1,293.15 million in 2025 and is projected to reach USD 3,883.76 million by 2033, growing at a CAGR of 14.87% from 2026 to 2033. The market is driven by advancements in next-generation sequencing (NGS), increased awa... Read More »
April 2026The global drug testing market size was estimated at USD 7.09 billion in 2025 and is projected to reach USD 11.55 billion by 2033, growing at a CAGR of 6.32% from 2026 to 2033. The rising prevalence of substance abuse worldwide has increased the demand for testing solutions.... Read More »
April 2026The global rapid tests market size was estimated at USD 12.76 billion in 2025 and is projected to reach USD 19.30 billion by 2033, growing at a CAGR of 5.31% from 2026 to 2033. The growth can be attributed to the growing geriatric population, rising target disease burden, and increasing ... Read More »
April 2026The global activated clotting time testing market size was estimated at USD 1.19 billion in 2025 and is projected to reach USD 2.13 billion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. The growth of the market is driven by the increasing cardiovascular disease prevalence, growin... Read More »
March 2026The global microsampling & minimally invasive blood collection market size was estimated at USD 2.16 billion in 2025 and is projected to reach USD 4.01 billion by 2033, growing at a CAGR of 8.15% from 2026 to 2033. The growth is driven by the increasing global burden of chronic condi... Read More »
March 2026The global colorectal cancer diagnostics market size was estimated at USD 9.53 billion in 2025 and is projected to reach USD 14.39 billion by 2033, growing at a CAGR of 5.34% from 2026 to 2033. The industry is driven by the increasing incidence of colorectal cancer, rising demand for ear... Read More »
March 2026The global syphilis testing market size was estimated at USD 1.57 billion in 2025 and is projected to reach USD 2.32 billion by 2033, growing at a CAGR of 5.23% from 2026 to 2033. Key market drivers for dual HIV/syphilis rapid diagnostics include the rising global burden of congenital sy... Read More »
March 2026